Georgetown University Medical Center Lombardi Cancer Center is a clinical research site located in Washington D.C., District of Columbia, United States 20007.
Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.
Georgetown University Medical Center Lombardi Cancer Center has participated in 20 clinical trials with 3 currently active.
Therapeutic areas: Mantle Cell Lymphoma, Breast Cancer, Cholangiocarcinoma.
Sponsors: Millennium Pharmaceuticals, Inc., Hoffmann-La Roche, Gilead Sciences.
Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Georgetown University Medical Center Lombardi Cancer Center has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Georgetown University Medical Center Lombardi Cancer Center has 20 clinical trials on record, with 3 currently active. Their work covers Mantle Cell Lymphoma, Breast Cancer, Cholangiocarcinoma.
Yes — Georgetown University Medical Center Lombardi Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.